E. Baldini

Randomized Open-Label Controlled Study of Cancer Vaccine OSE2101 Versus Chemotherapy in HLA-A2-positive Patients with Advanced Non-Small Cell Lung Cancer with Resistance to Immunotherapy: ATALANTE-1.

E. Felip, R. Dziadziuszko, A. Delmonte, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡

N. Biglia, A. Brandes, A. Musolino, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive Cohort

M. Ambrogi, M. Lucchi, C. Zirafa, 2024, Cancers.

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.

A. Gadducci, A. Lissoni, S. Cosio, 2024, The Lancet. Oncology.